Joseph Scaduto Email

Co-Founder and CEO . CMTx Biotech

Stony Brook, NY

Location

Current Roles

Employees:
11
Revenue:
$1.7M
About
CMTx Biotech is a clinical-stage biopharmaceutical company that is aggressively developing an orally-administered small molecule for the treatment of COVID-19 patients. The company is currently preparing to advance into a Phase II clinical trial to demonstrate the safety and efficacy of our lead drug candidate in hospitalized COVID-19 patients. Our clinical-stage drug candidate has already demonstrated impressive efficacy in a number of animal models of acute respiratory distress syndrome (ARDS) across multiple species (rats, mice, pigs, sheep). It has also been evaluated in several Phase I/II clinical studies, which showed that the drug is well-tolerated. CMTx Biotech also has a pipeline of pre-clinical stage analogues for the treatment of rare diseases.
CMTx Biotech Address
25 Health Sciences Drive
Stony Brook, NY
CMTx Biotech Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.